175 related articles for article (PubMed ID: 15704607)
1. Observational cohort study to monitor the use and safety of carvedilol in the treatment of heart failure in clinical practice in England--1st interim report.
Acharya NV; Wilton LV; Shakir SA
Int J Clin Pharmacol Ther; 2005 Jan; 43(1):1-6. PubMed ID: 15704607
[TBL] [Abstract][Full Text] [Related]
2. Use and risk management of carvedilol for the treatment of heart failure in the community in England: results from a modified prescription-event monitoring study.
Aurich-Barrera B; Wilton LV; Shakir SA
Drug Saf; 2009; 32(1):43-54. PubMed ID: 19132804
[TBL] [Abstract][Full Text] [Related]
3. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.
Macdonald PS; Keogh AM; Aboyoun CL; Lund M; Amor R; McCaffrey DJ
J Am Coll Cardiol; 1999 Mar; 33(4):924-31. PubMed ID: 10091817
[TBL] [Abstract][Full Text] [Related]
4. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure.
Krum H; Ninio D; MacDonald P
Heart; 2000 Dec; 84(6):615-9. PubMed ID: 11083738
[TBL] [Abstract][Full Text] [Related]
5. Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure.
Tarantini L; Cioffi G; Opasich C; Di Lenarda A; Pulignano G; Del Sindaco D; De Feo S; Stefenelli C; Russo P; Catania G
Ital Heart J; 2004 Jun; 5(6):441-9. PubMed ID: 15320569
[TBL] [Abstract][Full Text] [Related]
6. Effect of carvedilol on survival in severe chronic heart failure.
Packer M; Coats AJ; Fowler MB; Katus HA; Krum H; Mohacsi P; Rouleau JL; Tendera M; Castaigne A; Roecker EB; Schultz MK; DeMets DL;
N Engl J Med; 2001 May; 344(22):1651-8. PubMed ID: 11386263
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
Dunn CJ; Lea AP; Wagstaff AJ
Drugs; 1997 Jul; 54(1):161-85. PubMed ID: 9211087
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure.
Del Sindaco D; Pulignano G; Cioffi G; Tarantini L; Di Lenarda A; De Feo S; Opasich C; Minardi G; Giovannini E; Leggio F
J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):675-82. PubMed ID: 17700396
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group.
Colucci WS; Packer M; Bristow MR; Gilbert EM; Cohn JN; Fowler MB; Krueger SK; Hershberger R; Uretsky BF; Bowers JA; Sackner-Bernstein JD; Young ST; Holcslaw TL; Lukas MA
Circulation; 1996 Dec; 94(11):2800-6. PubMed ID: 8941105
[TBL] [Abstract][Full Text] [Related]
11. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
Torp-Pedersen C; Metra M; Charlesworth A; Spark P; Lukas MA; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Remme WJ; Scherhag A;
Heart; 2007 Aug; 93(8):968-73. PubMed ID: 17237130
[TBL] [Abstract][Full Text] [Related]
12. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study.
Krum H; Roecker EB; Mohacsi P; Rouleau JL; Tendera M; Coats AJ; Katus HA; Fowler MB; Packer M;
JAMA; 2003 Feb; 289(6):712-8. PubMed ID: 12585949
[TBL] [Abstract][Full Text] [Related]
13. Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?
Cioffi G; De Feo S; Pulignano G; Del Sindaco D; Tarantini L; Stefenelli C; Opasich C
Int J Cardiol; 2006 Feb; 107(2):220-4. PubMed ID: 16412800
[TBL] [Abstract][Full Text] [Related]
14. Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure.
Macdonald PS; Keogh AM; Aboyoun C; Lund M; Amor R; McCaffrey D
Heart; 1999 Nov; 82(5):589-93. PubMed ID: 10525515
[TBL] [Abstract][Full Text] [Related]
15. Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry.
Nul D; Zambrano C; Diaz A; Ferrante D; Varini S; Soifer S; Grancelli H; Doval H;
Cardiovasc Drugs Ther; 2005 Mar; 19(2):125-34. PubMed ID: 16025231
[TBL] [Abstract][Full Text] [Related]
16. Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
Lindenfeld J; Lowes BD; Bristow MR
Ann Pharmacother; 1999 Dec; 33(12):1266-9. PubMed ID: 10630826
[TBL] [Abstract][Full Text] [Related]
17. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
[TBL] [Abstract][Full Text] [Related]
18. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.
Packer M; Fowler MB; Roecker EB; Coats AJ; Katus HA; Krum H; Mohacsi P; Rouleau JL; Tendera M; Staiger C; Holcslaw TL; Amann-Zalan I; DeMets DL;
Circulation; 2002 Oct; 106(17):2194-9. PubMed ID: 12390947
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol for heart failure, with care.
Cleland JG; Swedberg K
Lancet; 1996 May; 347(9010):1199-201. PubMed ID: 8622445
[No Abstract] [Full Text] [Related]
20. Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus.
Nodari S; Metra M; Dei Cas A; Dei Cas L
Eur J Heart Fail; 2003 Dec; 5(6):803-9. PubMed ID: 14675859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
